TY - JOUR
T1 - Robot-assisted radical prostatectomy with the Hugo™ robot-assisted surgery system
T2 - A single-center initial experience in Japan
AU - Takahara, Kiyoshi
AU - Motonaga, Tomonari
AU - Nakamura, Wataru
AU - Saruta, Masanobu
AU - Nukaya, Takuhisa
AU - Takenaka, Masashi
AU - Zennami, Kenji
AU - Ichino, Manabu
AU - Sasaki, Hitomi
AU - Shiroki, Ryoichi
N1 - Publisher Copyright:
© 2024 The Author(s). Asian Journal of Endoscopic Surgery published by Asia Endosurgery Task Force and Japan Society of Endoscopic Surgery and John Wiley & Sons Australia, Ltd.
PY - 2024/7
Y1 - 2024/7
N2 - Background: Recently, various novel robotic systems have been put into clinical use. The aim of the present study was to assess the perioperative outcomes of robot-assisted radical prostatectomy (RARP) using the Hugo™ RAS system, one of brand-new robot-assisted surgical platforms. Methods: We performed RARP with the Hugo™ RAS system in 13 cases of localized prostate cancer (PCa) between August 2023 and February 2024 at our hospital. The perioperative outcomes of these 13 patients were assessed. Results: The median operative and console times were 197 (interquartile range [IQR], 187–228) and 134 min (IQR, 125–157), respectively. The median docking time was 7 min (IQR, 6–10), and the median estimated blood loss was 150 mL (IQR, 80–250). The vesical catheter was removed on postoperative day 6 in all cases. A positive surgical margin was observed in one patient (7.7%), and none experienced major perioperative complications, defined as Clavien–Dindo classification ≥3. The median postoperative length of stay was 8 days (IQR, 8–8.5). Conclusions: This was the first study to focus on RARP using the Hugo™ RAS system in Japan. Although further investigations should be conducted to assess the long-term oncological and functional outcomes, the Hugo™ RAS system could provide safe and favorable perioperative outcomes for patients with localized PCa undergoing RARP.
AB - Background: Recently, various novel robotic systems have been put into clinical use. The aim of the present study was to assess the perioperative outcomes of robot-assisted radical prostatectomy (RARP) using the Hugo™ RAS system, one of brand-new robot-assisted surgical platforms. Methods: We performed RARP with the Hugo™ RAS system in 13 cases of localized prostate cancer (PCa) between August 2023 and February 2024 at our hospital. The perioperative outcomes of these 13 patients were assessed. Results: The median operative and console times were 197 (interquartile range [IQR], 187–228) and 134 min (IQR, 125–157), respectively. The median docking time was 7 min (IQR, 6–10), and the median estimated blood loss was 150 mL (IQR, 80–250). The vesical catheter was removed on postoperative day 6 in all cases. A positive surgical margin was observed in one patient (7.7%), and none experienced major perioperative complications, defined as Clavien–Dindo classification ≥3. The median postoperative length of stay was 8 days (IQR, 8–8.5). Conclusions: This was the first study to focus on RARP using the Hugo™ RAS system in Japan. Although further investigations should be conducted to assess the long-term oncological and functional outcomes, the Hugo™ RAS system could provide safe and favorable perioperative outcomes for patients with localized PCa undergoing RARP.
UR - http://www.scopus.com/inward/record.url?scp=85196265156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196265156&partnerID=8YFLogxK
U2 - 10.1111/ases.13342
DO - 10.1111/ases.13342
M3 - Article
C2 - 38889908
AN - SCOPUS:85196265156
SN - 1758-5902
VL - 17
JO - Asian journal of endoscopic surgery
JF - Asian journal of endoscopic surgery
IS - 3
M1 - e13342
ER -